99 related articles for article (PubMed ID: 33778953)
21. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
22. Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013.
Fried DA; Sadeghi-Nejad H; Gu D; Zhou S; He W; Giordano SH; Pentakota SR; Demissie K; Helmer D; Shen C
Cancer Med; 2019 May; 8(5):2612-2622. PubMed ID: 30945473
[TBL] [Abstract][Full Text] [Related]
23. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
[TBL] [Abstract][Full Text] [Related]
24. Use of health services by previously uninsured Medicare beneficiaries.
McWilliams JM; Meara E; Zaslavsky AM; Ayanian JZ
N Engl J Med; 2007 Jul; 357(2):143-53. PubMed ID: 17625126
[TBL] [Abstract][Full Text] [Related]
25. Surgical treatment of colon cancer in patients aged 80 years and older : analysis of 31,574 patients in the SEER-Medicare database.
Neuman HB; O'Connor ES; Weiss J; Loconte NK; Greenblatt DY; Greenberg CC; Smith MA
Cancer; 2013 Feb; 119(3):639-47. PubMed ID: 22893570
[TBL] [Abstract][Full Text] [Related]
26. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
27. Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage.
Pfister DG; Rubin DM; Elkin EB; Neill US; Duck E; Radzyner M; Bach PB
JAMA Oncol; 2015 Dec; 1(9):1303-10. PubMed ID: 26448610
[TBL] [Abstract][Full Text] [Related]
28. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer.
Fossati N; Nguyen DP; Trinh QD; Sammon J; Sood A; Larcher A; Guazzoni G; Montorsi F; Briganti A; Menon M; Abdollah F
J Natl Compr Canc Netw; 2015 Nov; 13(11):1351-8. PubMed ID: 26553765
[TBL] [Abstract][Full Text] [Related]
30. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
[TBL] [Abstract][Full Text] [Related]
32. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
34. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
35. Measuring the incidence of cancer in elderly Americans using Medicare claims data.
McBean AM; Warren JL; Babish JD
Cancer; 1994 May; 73(9):2417-25. PubMed ID: 8168045
[TBL] [Abstract][Full Text] [Related]
36. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
37. High-cost imaging in elderly patients with stage IV cancer.
Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
[TBL] [Abstract][Full Text] [Related]
39. National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management Decisions.
Weiner AB; Conti RM; Eggener SE
J Urol; 2016 May; 195(5):1383-1389. PubMed ID: 26707507
[TBL] [Abstract][Full Text] [Related]
40. End-of-life care for lung cancer patients in the United States and Ontario.
Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
